Position in GILD
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$371,439
-$30,782 QoQ
Shares Held
2,940
+1.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#1,538
of 2,266 holders
Holding Since
Jun 2022
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MJP ASSOCIATES INC /ADV holds $12,749,028 across 8 Drug Manufacturers - General names. GILD ranks #7 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,834 | $4,598,615 | |
| 2 | MRK |
Merck & Co., Inc.
|
16,086 | $2,067,051 | |
| 3 | ABBV |
AbbVie Inc.
|
8,151 | $2,051,117 | |
| 4 | JNJ |
Johnson & Johnson
|
7,837 | $1,990,362 | |
| 5 | AMGN |
Amgen Inc
|
2,286 | $827,806 | |
| 6 | PFE |
Pfizer Inc
|
21,634 | $520,946 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
2,940 | $371,439 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,583 | $321,692 |
All Filings in GILD
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $371,439 | 2,940 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $402,221 | 2,886 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $326,611 | 2,661 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $236,319 | 2,129 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $205,442 | 1,853 | Shares | Sole | 2025-08-08 | |
| 2023-06-30 | $464,192 | 6,023 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $579,960 | 6,990 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $564,721 | 6,578 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $352,434 | 5,713 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $304,723 | 4,930 | Shares | Sole | 2022-07-11 | |
| No filing history on record for this holder in this stock. | ||||||